Significant Decrease in Annual Cancer Diagnoses in Spain during the COVID-19 Pandemic: A Real-Data Study.
Significant Decrease in Annual Cancer Diagnoses in Spain during the COVID-19 Pandemic: A Real-Data Study.
复制标题
DOI：
10.3390/cancers13133215
复制
发表时间：
2021-06-28
期刊：
影响因子：
5.2
通讯作者：
Ribelles N
中科院分区：
文献类型：
--
作者：
Ruiz-Medina S;Gil S;Jimenez B;Rodriguez-Brazzarola P;Diaz-Redondo T;Cazorla M;Muñoz-Ayllon M;Ramos I;Reyna C;Bermejo MJ;Godoy A;Torres E;Cobo M;Galvez L;Rueda A;Alba E;Ribelles N
毫无疑问，卫生系统为应对COVID-19大流行而经历了转型，但这可能对癌症等其他疾病产生了负面影响。我们分析了两所大学医院在大流行后第一年诊断出的所有癌症患者，这些医院共有785，000人，并将其与2019年诊断出的患者进行了比较。我们的研究结果清楚地表明，在大流行后的第一年，诊断患有癌症的患者人数显著减少了17.2%。然而，2018年至2019年或2017年至2019年之间确诊的患者数量没有差异，因此癌症患者的损失可能归因于大流行导致的卫生系统变化。诊断的延误可能对癌症患者的预后产生重要影响，因此卫生系统应作出类似于对大流行病所作的努力，以恢复所有尚未确诊的患者。COVID-19大流行导致基层及医院护理层面的卫生组织发生深刻变化。这项横断面研究旨在调查COVID-19大流行对两所大学附属医院每年新发癌症诊断率的影响。这项研究包括在大流行第一年在马拉加（西班牙）两家医院就诊的所有病理诊断为癌症的患者。该研究人群与2019年前一年诊断的患者进行了比较。为了分析年确诊率的可能差异是由于大流行还是其他原因，还比较了2018年和2017年期间确诊的患者。与2019年的2825例患者相比，有2340例新的癌症诊断，下降了-17.2%（p = 0.0001）。2018年至2019年（2840例新病例;增加0.5%）或2017年至2019年（2909例新病例;增加3%）诊断出的癌症患者数量差异无统计学意义。2020年，失诊人数最多的是乳腺癌（-26.1%）、结直肠肿瘤（-16.9%）和头颈部肿瘤（-19.8%）。对COVID-19大流行第一年发病率的研究表明，新癌症患者的诊断受到了显著影响。卫生系统必须采取必要措施，恢复大流行病前的诊断程序，并恢复没有得到诊断的病人。
There is no doubt about the transformation that health systems have undergone in response to the COVID-19 pandemic, but this may have had a negative impact on other diseases such as cancer. We have analyzed all the cancer patients diagnosed in the first post-pandemic year in two university hospitals that attend 785,000 people and compared them with patients diagnosed in 2019. Our results clearly show that during the first post-pandemic year there has been a significant decrease of 17.2% in the number of patients diagnosed with cancer. However, there were no differences in the number of patients diagnosed between 2018 and 2019 or between 2017 and 2019, so that loss of cancer patients could be attributed to changes made in health systems due to the pandemic. The delay in the diagnosis may have important consequences in the prognosis of cancer patients, so health systems should carry out an effort similar to that made with the pandemic to recover all lost patients who have remained undiagnosed. The COVID-19 pandemic has caused a profound change in health organizations at both the primary and hospital care levels. This cross-sectional study aims to investigate the impact of the COVID-19 pandemic in the annual rate of new cancer diagnosis in two university-affiliated hospitals. This study includes all the patients with a pathological diagnosis of cancer attended in two hospitals in Málaga (Spain) during the first year of pandemic. This study population was compared with the patients diagnosed during the previous year 2019. To analyze whether the possible differences in the annual rate of diagnoses were due to the pandemic or to other causes, the patients diagnosed during 2018 and 2017 were also compared. There were 2340 new cancer diagnosis compared to 2825 patients in 2019 which represented a decrease of −17.2% (p = 0.0001). Differences in the number of cancer patients diagnosed between 2018 and 2019 (2840 new cases; 0.5% increase) or 2017 and 2019 (2909 new cases; 3% increase) were not statistically significant. The highest number of patients lost from diagnosis in 2020 was in breast cancer (−26.1%), colorectal neoplasms (−16.9%), and head and neck tumors (−19.8%). The study of incidence rates throughout the first year of the COVID-19 pandemic shows that the diagnosis of new cancer patients has been significantly impaired. Health systems must take the necessary measures to restore pre-pandemic diagnostic procedures and to recover lost patients who have not been diagnosed.
登录
查看更多内容
影响因子：
6.2
作者：
Nyante SJ;Benefield TS;Kuzmiak CM;Earnhardt K;Pritchard M;Henderson LM
通讯作者：
Henderson LM
共同-19大流行对西班牙癌症患者的护理的影响。
影响因子：
7.3
作者：
Amador M;Matias-Guiu X;Sancho-Pardo G;Contreras Martinez J;de la Torre-Montero JC;Peñuelas Saiz A;Garrido P;García-Sanz R;Rodríguez-Lescure Á;Paz-Ares L
通讯作者：
Paz-Ares L
影响因子：
2.3
作者：
Vanni, Gianluca;Materazzo, Marco;Buonomo, Oreste Claudio
通讯作者：
Buonomo, Oreste Claudio
影响因子：
3.8
作者：
Park JY;Lee YJ;Kim T;Lee CY;Kim HI;Kim JH;Park S;Hwang YI;Jung KS;Jang SH
通讯作者：
Jang SH
影响因子：
3.5
作者：
Ferrara, Gerardo;De Vincentiis, Ludovica;Saragoni, Luca
通讯作者：
Saragoni, Luca